Join
Live feed
·
INSIDERFilingvia Quantisnow
Teva Pharmaceutical Industries Limited logo

President and CEO Francis Richard D converted options into 42,452 units of Ordinary Shares and sold $634,160 worth of Ordinary Shares (20,025 units at $31.67), increasing direct ownership by 2% to 1,170,639 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEVA (Teva Pharmaceutical Industries Limited) and more on Quantisnow.